LONDON (Reuters) -GSK raised its 2025 sales and earnings forecasts on Wednesday as its speciality HIV and cancer drugs posted double digit growth, lifting the British company's shares by nearly 7% to ...

With tariffs causing markets to waver in 2025, many investors were growing worried about the guidance companies would put out. Analysts expect certain stocks not to give guidance for the rest of the ...

Henry Schein (HSIC) shares rose following the company's updated forecast for adjusted profit and sales growth for the year. The company revised its 2025 adjusted profit estimate to a range of $4.88 to ...

As "Avatar: Fire and Ash" headed to the big screen this month, theater owners held their breath. In an uneven year that saw two billion-dollar hits and a viral "chicken jockey" craze, but also a ...